Japan’s push to modernise clinical research through artificial intelligence and [...]

Remepy has announced a collaboration with Merck KGaA, Darmstadt Germany, [...]

RxLogix has launched a new version of its PVOne.AI platform [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

Viz.ai has entered a collaboration with Johnson & Johnson to [...]

Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

Merck has launched a portfolio of bio-based solvents for high-performance [...]

Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]